Search Results
May 18, 2026, 07:14 ET Haier po raz ósmy z rzędu jedyną na świecie marką ekosystemu IoT w rankingu Kantar BrandZ Top 100
QINGDAO (Chiny), 18 maja 2026 r. /PRNewswire/ -- Kantar, światowy lider w dziedzinie danych o markach i doradztwa strategicznego, opublikował właśnie ranking BrandZ 2026 Top 100 - zestawienie 100 najcenniejszych marek globalnych.
More news about: Haier
May 18, 2026, 07:09 ET Einride AB and Legato Merger Corp. III Announce Effectiveness of Registration Statement Ahead of Planned Business Combination and Nasdaq Listing
https://news.cision.com/einride/r/einride-ab-and-legato-merger-corp--iii-announce-effectiveness-of-registration-statement-ahead-of-pla,c4349409The following files are available for download:
More news about: Einride
May 18, 2026, 07:06 ET Einride AB and Legato Merger Corp. III Announce Effectiveness of Registration Statement Ahead of Planned Business Combination and Nasdaq Listing
https://news.cision.com/einride/r/einride-ab-and-legato-merger-corp--iii-announce-effectiveness-of-registration-statement-ahead-of-pla,c4349409The following files are available for download:
More news about: Einride
May 18, 2026, 07:00 ET Triquetra Health Launches FolinicActive™--First Multi-Pathway Active Folate with Complete Tri-Cofactor System
coverage, active B-6 as pyridoxal-5′-phosphate (P-5-P, 5 mg) to support an additional homocysteine pathway, and active B-2 as riboflavin-5′-phosphate (R-5-P, 2 mg), the cofactor MTHFR enzyme requires to function. Published research by McNulty et al. (2023, Proceedings of the Nutrition Society) demonstrated
More news about: Triquetra Health LLC
May 18, 2026, 07:00 ET Bracco and ACIST Medical Systems Announce U.S. FDA Clearance of ACIST Pro™ Diagnostic System
volume on risk of contrast-induced nephropathy. Am J Cardiol 113 (1): 49-53.2 Call J, Sacrinty M, Applegate R, Little W, Santos R et al. (2006) Automated contrast injection in contemporary practice during cardiac catheterization and PCI: effects on contrast-induced nephropathy.
More news about: Bracco Group
May 18, 2026, 07:00 ET Earendil Labs Announces First Cohort Dosed in Phase I Study of Novel Biparatopic Antibody Targeting Thymic Stromal Lymphopoietin (TSLP)
patients with autoimmune diseases, cancer, and other areas of significant unmet medical need. By integrating artificial intelligence across the full R&D lifecycle, Earendil Labs and its affiliate Helixon Therapeutics have been building a scalable engine to systematically generate and advance high-quality
More news about: Earendil Labs
May 18, 2026, 07:00 ET Compliance Crisis Stalling US-Latin America Crypto Deals, BRACKT AI Data Reveals
BRACKT AI, providing real-time compliance analysis across multiple jurisdictions. He formerly served as Chief Product Officer at AppViewX, as R&D/Internet of Things Senior Director at VMware, and as Senior Director of Product Management at AirWatch by VMware.
More news about: Brackt
May 18, 2026, 07:00 ET Triquetra Health Launches FolinicActive™ Adult Liquid--First Multi-Pathway Active Folate with Complete Tri-Cofactor System
methylcobalamin, 10% adenosylcobalamin, 10% hydroxocobalamin), 5 mg active B-6 as pyridoxal-5′-phosphate (P-5-P), and 2 mg active B-2 as riboflavin-5′-phosphate (R-5-P). The formula is USDA Organic certified, made with an organic glycerin base and organic flavoring, with no artificial colors, flavors, or preservatives.
More news about: Triquetra Health LLC
May 18, 2026, 07:00 ET Compugen Reports First Quarter 2026 Results
and 2025 reflect recognition of portions of both the upfront payment and the IND milestone payment from the license agreement with Gilead. R&D expenses for the first quarter of 2026 were approximately $6.9 million compared with approximately $5.8 million for the comparable period in 2025. The
More news about: Compugen Ltd.
May 18, 2026, 06:59 ET Industrial Portable Generator Market worth $0.75 billion by 2030 | MarketsandMarkets™
through its export facility, over 5 million customers worldwide, and 42 research and development (R&D) centers across Europe, North America, South America, and Asia, particularly China and Japan. It has 15 R&D centers in North America, which helped it analyze the requirements of its customers and align
More news about: MarketsandMarkets
May 18, 2026, 06:50 ET Peter Menziuso Named EVP and President, BD Interventional
as Company Group Chairman of Johnson & Johnson Vision, where he led a $5 billion global business with responsibility for commercial operations, R&D, supply chain, quality, finance and medical affairs.Throughout his career, Menziuso has been recognized for strengthening market leadership,
More news about: BD (Becton, Dickinson and Company)
May 18, 2026, 06:08 ET CHERY oficjalnie ogłasza, że Robert Lewandowski został globalnym ambasadorem marki, umacniając światowy przekaz filozofii marki „Dla rodziny"
BARCELONA (Hiszpania), 18 maja 2026 r. /PRNewswire/ -- Marka CHERY oficjalnie ogłosiła w swojej europejskiej siedzibie operacyjnej w Barcelonie, że światowej sławy ikona piłki nożnej Robert Lewandowski przyjął rolę globalnego
More news about: Chery Automobile Co., Ltd.
May 18, 2026, 06:00 ET Judge Anthony Devos Johnstone to LMU Loyola Law School Grads: "May Your Work Continue the Cause of Human Dignity"
and philosophy of law, and was widely respected for his thoughtful and rigorous approach to legal education. Johnstone also clerked for Judge Sidney R. Thomas of the Ninth Circuit, an experience that helped shape his deep understanding of judicial decision-making and appellate practice.This year's
More news about: Loyola Marymount University
May 18, 2026, 04:47 ET Lundbeck receives orphan drug designation in Japan for asedebart for the treatment of patients with congenital adrenal hyperplasia and Cushing's disease
2020;383(13):1248-61Lousada LM, et al. Arch Endocrinol Metab 2021;65(4):488-94 Han TS, et al. Nat Rev Endocrinol 2014;10(2):115-24Pofi R, et al. Clin Endocrinol (Oxf) 2023Auchus RJ, et al. Front Endocrinol (Lausanne) 2022;13:1005963CONTACT: H. Lundbeck
More news about: H. Lundbeck A/S
May 18, 2026, 04:31 ET 康霈首登 ECO 2026 口頭發表 CBL-514 併用 GLP-1R 類減重藥物動物數據 全身性代謝效果吸引國際專家及大藥廠高度興趣
與 GLP-1R 類減重藥物併用，在動物實驗中除體重維持與脂肪減少外，亦呈現改善肝臟代謝與發炎狀態之潛在科學意義。康霈副總鍾琭璣表示：「我們很榮幸由 Dr. Sharma 這樣具國際影響力的肥胖醫學權威，於 ECO 2026 向全球肥胖與代謝領域專家發表 CBL-514 與 GLP-1R 類減重藥物併用之動物實驗數據。本次口頭發表現場參與度高，吸引超過300位聽眾，包括跨國藥廠代表、臨床醫師、專家學者及產業人士，有助於提升 CBL-514 在國際肥胖與代謝領域的能見度，並深化與關鍵潛在合作夥伴的交流。」鍾琭璣副總進一步指出：「隨著 GLP-1R 類藥物快速
More news about: 康霈生技
May 18, 2026, 03:56 ET Implantica presents the first quarter (Q1 2026) on May 22 at 15:00 CET
https://news.cision.com/implantica/r/implantica-presents-the-first-quarter--q1-2026--on-may-22-at-15-00-cet,c4349043The following files are available for download:
More news about: Implantica
May 18, 2026, 03:49 ET Cactus Communications präsentiert Lösungen für die Forschungsforschung auf der 114. BiblioCon 2026 und stärkt das Engagement für das akademische Ökosystem in Deutschland
Fachwissen mit speziell entwickelter KI kombinieren. Mit der Forschungsplattform R Discovery will CACTUS Forschern, Bibliotheken und Institutionen helfen, den Zugang zu relevanten Forschungsergebnissen durch KI-gestützte Suche und
More news about: Cactus Communications
May 18, 2026, 03:47 ET Cactus Communications to showcase research discovery solutions at 114. BiblioCon 2026, strengthening engagement with Germany's academic ecosystem
showcase solutions that combine human expertise with purpose-built AI. Through R Discovery, its research discovery platform, CACTUS aims to help researchers, libraries, and institutions improve access to relevant research through
More news about: Cactus Communications
May 18, 2026, 03:39 ET Valmet's new R&D program Industrial NEXUS advances industrial renewal through an ecosystem focused on digital technologies and operating models
President, Strategic R&D at Valmet.The program is partly funded by Business Finland as part of its leading company program initiative. Through the program, domestic and international ecosystem partners will be invited to address societal challenges and strengthen R&D investments in Finland.More
More news about: Valmet Oyj
May 18, 2026, 03:22 ET Scania to provide 91 battery-electric buses in Sweden
https://news.cision.com/scania/r/scania-to-provide-91-battery-electric-buses-in-sweden,c4348564The following files are available for download:
More news about: Scania
May 18, 2026, 03:04 ET Share buybacks in Ericsson during the period May 11 - May 15, 2026
https://news.cision.com/ericsson/r/share-buybacks-in-ericsson-during-the-period-may-11---may-15--2026,c4349222The following files are available for download:
More news about: Ericsson
May 18, 2026, 03:00 ET Augury Shaping the Future of Production with the Industrial AI Workforce
Avi Boublil, R&D Director at ICL Iberia. "In our work with the Reliability and Operations agents, we have already seen the potential for much quicker Root Cause
More news about: Augury
May 18, 2026, 02:59 ET Share buybacks in Ericsson during the period May 11 - May 15, 2026
https://news.cision.com/ericsson/r/share-buybacks-in-ericsson-during-the-period-may-11---may-15--2026,c4349222The following files are available for download:
More news about: Ericsson
May 18, 2026, 02:56 ET SciBase Announces New Research Highlighting Nevisense's Potential in Detecting Age-Related Skin Barrier Changes
https://news.cision.com/scibase/r/scibase-announces-new-research-highlighting-nevisense-s-potential-in-detecting-age-related-skin-barr,c4349354The following files are available for download:
More news about: SciBase
May 18, 2026, 02:41 ET SciBase Announces New Research Highlighting Nevisense's Potential in Detecting Age-Related Skin Barrier Changes
https://news.cision.com/scibase/r/scibase-announces-new-research-highlighting-nevisense-s-potential-in-detecting-age-related-skin-barr,c4349354The following files are available for download:
More news about: SciBase